Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке:
https://open.uns.ac.rs/handle/123456789/1706
Назив: | Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants | Аутори: | Eikelboom J. Kozek-Langenecker S. Exadaktylos A. Batorova A. Boda Z. Christory F. Gornik I. Kėkštas G. Kher A. Komadina R. Koval O. Mitić, Gorana Novikova T. Pazvanska E. Ratobilska S. Sütt J. Winder A. Zateyshchikov D. |
Датум издавања: | 1-апр-2018 | Часопис: | British Journal of Anaesthesia | Сажетак: | © 2017 The Author(s) Non-vitamin K antagonist oral anticoagulants (NOACs), which inhibit thrombin (dabigatran) and factor Xa (rivaroxaban, apixaban, edoxaban) have been introduced in several clinical indications. Although NOACs have a favourable benefit-risk profile and can be used without routine laboratory monitoring, they are associated–as any anticoagulant–with a risk of bleeding. In addition, treatment may need to be interrupted in patients who need surgery or other procedures. The objective of this article, developed by a multidisciplinary panel of experts in thrombosis and haemostasis, is to provide an update on the management of NOAC-treated patients who experience a bleeding episode or require an urgent procedure. Recent advances in the development of targeted reversal agents are expected to help streamline the management of NOAC-treated patients in whom rapid reversal of anticoagulation is required. | URI: | https://open.uns.ac.rs/handle/123456789/1706 | ISSN: | 70912 | DOI: | 10.1016/j.bja.2017.11.082 |
Налази се у колекцијама: | MDF Publikacije/Publications |
Приказати целокупан запис ставки
SCOPUSTM
Навођења
16
проверено 10.05.2024.
Преглед/и станица
14
Протекла недеља
5
5
Протекли месец
0
0
проверено 10.05.2024.
Google ScholarTM
Проверите
Алт метрика
Ставке на DSpace-у су заштићене ауторским правима, са свим правима задржаним, осим ако није другачије назначено.